Patents by Inventor Pil-Ho Kim

Pil-Ho Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250082762
    Abstract: The present invention relates to a novel heterocyclic compound and a composition, for preventing or treating a cancer, an autoimmune disease, and an inflammatory disease, comprising same. The novel heterocyclic compound of the present invention is a bifunctional compound having a Bruton's tyrosine kinase (BTK) degradation function via a ubiquitin proteasome pathway, and may be utilized as a composition for preventing or treating a cancer, an autoimmune disease, and Parkinson's disease.
    Type: Application
    Filed: November 15, 2024
    Publication date: March 13, 2025
    Applicants: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY, UBIX THERAPEUTICS, INC.
    Inventors: Pil Ho KIM, Sung Yun CHO, Jae Du HA, Chi Hoon PARK, Jong Yeon HWANG, Hyun Jin KIM, Song Hee LEE, Ye Seul LIM, Han Wool KIM, Sun Mi YOO, Beom Seon SUH, Ji Youn PARK, Je Ho RYU, Jung Min AHN, Hee Jung MOON, Ho Hyun LEE
  • Publication number: 20250073341
    Abstract: The present invention relates to a novel heterocyclic compound and a composition, for preventing or treating a cancer, an autoimmune disease, and an inflammatory disease, comprising same. The novel heterocyclic compound of the present invention is a bifunctional compound having a Bruton's tyrosine kinase (BTK) degradation function via a ubiquitin proteasome pathway, and may be utilized as a composition for preventing or treating a cancer, an autoimmune disease, and Parkinson's disease.
    Type: Application
    Filed: November 15, 2024
    Publication date: March 6, 2025
    Applicants: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY, UBIX THERAPEUTICS, INC.
    Inventors: Pil Ho KIM, Sung Yun CHO, Jae Du HA, Chi Hoon PARK, Jong Yeon HWANG, Hyun Jin KIM, Song Hee LEE, Ye Seul LIM, Han Wool KIM, Sun Mi YOO, Beom Seon SUH, Ji Youn PARK, Je Ho RYU, Jung Min AHN, Hee Jung MOON, Ho Hyun LEE
  • Patent number: 12161722
    Abstract: The present invention relates to a novel heterocyclic compound and a composition, for preventing or treating a cancer, an autoimmune disease, and an inflammatory disease, comprising same. The novel heterocyclic compound of the present invention is a bifunctional compound having a Bruton's tyrosine kinase (BTK) degradation function via a ubiquitin proteasome pathway, and may be utilized as a composition for preventing or treating a cancer, an autoimmune disease, and Parkinson's disease.
    Type: Grant
    Filed: June 24, 2022
    Date of Patent: December 10, 2024
    Assignees: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY, UBIX THERAPEUTICS, INC.
    Inventors: Pil Ho Kim, Sung Yun Cho, Jae Du Ha, Chi Hoon Park, Jong Yeon Hwang, Hyun Jin Kim, Song Hee Lee, Ye Seul Lim, Han Wool Kim, Sun Mi Yoo, Beom Seon Suh, Ji Youn Park, Je Ho Ryu, Jung Min Ahn, Hee Jung Moon, Ho Hyun Lee
  • Publication number: 20240285778
    Abstract: The present invention relates to a novel heterocyclic compound and a composition, for preventing or treating a cancer, an autoimmune disease, and an inflammatory disease, comprising same. The novel heterocyclic compound of the present invention is a bifunctional compound having a Bruton's tyrosine kinase (BTK) degradation function via a ubiquitin proteasome pathway, and may be utilized as a composition for preventing or treating a cancer, an autoimmune disease, and Parkinson's disease.
    Type: Application
    Filed: June 24, 2022
    Publication date: August 29, 2024
    Applicants: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY, UBIX THERAPEUTICS, INC.
    Inventors: Pil Ho KIM, Sung Yun CHO, Jae Du HA, Chi Hoon PARK, Jong Yeon HWANG, Hyun Jin KIM, Song Hee LEE, Ye Seul LIM, Han Wool KIM, Sun Mi YOO, Beom Seon SUH, Ji Youn PARK, Je Ho RYU, Jung Min AHN, Hee Jung MOON, Ho Hyun LEE
  • Publication number: 20240270698
    Abstract: The present invention relates to a novel pyrimidine derivative and a use thereof. The pyrimidine derivative has excellent MLK3 inhibitory activity and LRRK2 inhibitory activity and thus can be utilized in a pharmaceutical composition for preventing or treating cancers, virus infectious diseases, Parkinson's disease, nonalcoholic fatty liver disease, and tuberculosis.
    Type: Application
    Filed: December 16, 2020
    Publication date: August 15, 2024
    Applicant: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Pil Ho KIM, Seong Hwan KIM
  • Publication number: 20230348399
    Abstract: The present invention relates to a novel pyrimidine derivative and a use thereof. The pyrimidine derivative has excellent MLK3 inhibitory activity and LRRK2 inhibitory activity and thus can be utilized in a pharmaceutical composition for preventing or treating cancers, virus infectious diseases, Parkinson's disease, nonalcoholic fatty liver disease, and tuberculosis.
    Type: Application
    Filed: December 16, 2020
    Publication date: November 2, 2023
    Applicant: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Pil Ho KIM, Seong Hwan KIM
  • Patent number: 11694637
    Abstract: A display device according to an embodiment includes a plurality of pixel blocks including a plurality of pixels connected to a plurality of scan lines and a plurality of data lines, respectively, and at least one active circuit; and a data driver supplying a data voltage to the plurality of data lines in a light emitting mode and supplying a neural network input signal to the plurality of data lines in an artificial neural network mode. In the artificial neural network mode, a scan signal is supplied to a scan line connected to at least one pixel block among the plurality of pixel blocks, and the neural network input signal is supplied to a data line connected to the at least one pixel block.
    Type: Grant
    Filed: July 8, 2022
    Date of Patent: July 4, 2023
    Assignee: SAMSUNG DISPLAY CO., LTD.
    Inventors: Young Wook Yoo, Pil Ho Kim
  • Publication number: 20230116733
    Abstract: The present invention relates to a novel indazole derivative, and a use thereof, wherein the indazole derivative has excellent TRIB2 or YAP inhibitory activity, and can be effectively used as a pharmaceutical composition for preventing or treating cancer, narcolepsy, and fasciitis.
    Type: Application
    Filed: December 16, 2020
    Publication date: April 13, 2023
    Applicant: KOREA RESEARCH INSTITUTE OFCHEMICAL TECHNOLOGY
    Inventors: Pil Ho KIM, Seong Hwan KIM
  • Publication number: 20230008470
    Abstract: A display device according to an embodiment includes a plurality of pixel blocks including a plurality of pixels connected to a plurality of scan lines and a plurality of data lines, respectively, and at least one active circuit; and a data driver supplying a data voltage to the plurality of data lines in a light emitting mode and supplying a neural network input signal to the plurality of data lines in an artificial neural network mode. In the artificial neural network mode, a scan signal is supplied to a scan line connected to at least one pixel block among the plurality of pixel blocks, and the neural network input signal is supplied to a data line connected to the at least one pixel block.
    Type: Application
    Filed: July 8, 2022
    Publication date: January 12, 2023
    Inventors: Young Wook YOO, Pil Ho KIM
  • Patent number: 11352492
    Abstract: A thermoplastic resin composition of the present invention comprises: approximately 100 parts by weight of a polycarbonate resin; approximately 0.01-2 parts by weight of a modified aromatic vinyl-based copolymer resin; approximately 0.01-1 parts by weight of a metal aliphatic sulfonate; and approximately 0.01-2 parts by weight of a fluorinated olefin-based resin, wherein the modified aromatic vinyl-based copolymer resin is a polymer of a monomer mixture comprising an aromatic vinyl-based monomer and glycidyl (meth)acrylate. The thermoplastic resin composition has excellent flame retardancy, transparency and the like.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: June 7, 2022
    Assignee: Lotte Chemical Corporation
    Inventors: Su Ji Kim, Pil Ho Kim, Seung Shik Shin
  • Patent number: 11192878
    Abstract: The present disclosure relates to a novel piperidine-2,6-dione derivative and a use thereof and, more specifically, to a piperidine-2,6-dione derivative compound having a structure of a thalidomide analog. A compound of chemical formula 1 according to the present disclosure specifically binds with CRBN protein, and is involved in functions thereof. Therefore, the compound of the present disclosure can be favorably used in the prevention or treatment of leprosy, chronic graft versus host disease, an inflammatory disease, or cancer, which are caused by actions of CRBN protein.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: December 7, 2021
    Assignee: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Jong Yeon Hwang, Jae Du Ha, Sung Yun Cho, Pil Ho Kim, Chang Soo Yun, Chi Hoon Park, Chong Ock Lee, Sang Un Choi, Joo Youn Lee, Sunjoo Ahn
  • Publication number: 20200385572
    Abstract: A thermoplastic resin composition of the present invention comprises: approximately 100 parts by weight of a polycarbonate resin; approximately 0.01-2 parts by weight of a modified aromatic vinyl-based copolymer resin; approximately 0.01-1 parts by weight of a metal aliphatic sulfonate; and approximately 0.01-2 parts by weight of a fluorinated olefin-based resin, wherein the modified aromatic vinyl-based copolymer resin is a polymer of a monomer mixture comprising an aromatic vinyl-based monomer and glycidyl (meth)acrylate. The thermoplastic resin composition has excellent flame retardancy, transparency and the like.
    Type: Application
    Filed: December 28, 2018
    Publication date: December 10, 2020
    Inventors: Su Ji KIM, Pil Ho KIM, Seung Shik SHIN
  • Patent number: 10787567
    Abstract: A thermoplastic resin composition of the present invention contains: a polycarbonate resin; a siloxane copolymer comprising a repeat unit represented by chemical formula 1 and a repeat unit represented by chemical formula 2; a metal aromatic sulfonate; a fluorinated olefin-based resin; and an inorganic filler having a difference in refractive index with the polycarbonate resin of approximately 0-0.01. The thermoplastic resin composition has excellent flame retardancy, transparency, stiffness, heat resistance, balance of these physical properties, and the like.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: September 29, 2020
    Assignee: Lotte Advanced Materials Co., Ltd.
    Inventors: Pil Ho Kim, Su Ji Kim, Sun Young Kim, Seung Shik Shin
  • Publication number: 20200062730
    Abstract: The present disclosure relates to a novel piperidine-2,6-dione derivative and a use thereof and, more specifically, to a piperidine-2,6-dione derivative compound having a structure of a thalidomide analog. A compound of chemical formula 1 according to the present disclosure specifically binds with CRBN protein, and is involved in functions thereof. Therefore, the compound of the present disclosure can be favorably used in the prevention or treatment of leprosy, chronic graft versus host disease, an inflammatory disease, or cancer, which are caused by actions of CRBN protein.
    Type: Application
    Filed: May 11, 2018
    Publication date: February 27, 2020
    Inventors: Jong Yeon HWANG, Jae Du HA, Sung Yun CHO, Pil Ho KIM, Chang Soo YUN, Chi Hoon PARK, Chong Ock LEE, Sang Un CHOI, Joo Youn LEE, Sunjoo AHN
  • Publication number: 20180319979
    Abstract: A thermoplastic resin composition of the present invention contains: a polycarbonate resin; a siloxane copolymer comprising a repeat unit represented by chemical formula 1 and a repeat unit represented by chemical formula 2; a metal aromatic sulfonate; a fluorinated olefin-based resin; and an inorganic filler having a difference in refractive index with the polycarbonate resin of approximately 0-0.01. The thermoplastic resin composition has excellent flame retardancy, transparency, stiffness, heat resistance, balance of these physical properties, and the like.
    Type: Application
    Filed: December 13, 2016
    Publication date: November 8, 2018
    Applicant: LOTTE ADVANCED MATERIALS CO., LTD.
    Inventors: Pil Ho KIM, Su Ji KIM, Sun Young KIM, Seung Shik SHIN
  • Patent number: 9890133
    Abstract: Disclosed are novel indanone derivatives, pharmaceutically acceptable salts thereof or enantiomers, a preparation method thereof, and a pharmaceutical composition for the prevention or treatment of viral diseases, comprising the same as an active ingredient. The indanone derivatives have excellent inhibitory activity against picornaviruses including coxsackie-, entero-, echo-, Polio-, and rhinoviruses, as well as exhibiting low cytotoxicity, so that they can be useful as an active ingredient of a pharmaceutical composition for the prevention or treatment of viral diseases including poliomyelitis, paralysis, acute hemorrhagic conjunctivitis, viral meningitis, hand-foot-and-mouth disease, vesicular disease, hepatitis A, myositis, myocarditis, pancreatitis, diabetes, epidemic myalgia, encephalitis, cold, herpangina, foot-and-mouth disease, asthma, chronic obstructive pulmonary disease, pneumonia, sinusitis or otitis media.
    Type: Grant
    Filed: June 22, 2016
    Date of Patent: February 13, 2018
    Assignees: KATHOLIEKE UNIVERSITEIT LEUVEN K.U. LEUVEN R&D, KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Young Sik Jung, Chong Kgo Lee, Hae Soo Kim, Hee Chun Jeong, Pil Ho Kim, Soo Bong Han, Jin Soo Shin, Johan Neyts, Hendrik Jan Thibaut
  • Publication number: 20170275448
    Abstract: A thermoplastic resin composition of the present invention comprises: about 100 parts by weight of a polycarbonate resin; about 10 to about 140 parts by weight of a (meth)acrylic-based resin which comprises a repeating unit represented by chemical formula 1; about 10 to about 80 parts by weight of an aromatic phosphate ester-based compound; and about 10 to 110 parts by weight of a glass fiber, wherein the difference in refractive index between the glass fiber and a resin mixture comprising the polycarbonate resin, the (meth)acrylic-based resin, and the aromatic phosphate ester-based compound is about 0.02 or less. The thermoplastic resin composition has excellent transparency and mechanical strength such as impact resistance, flexural modulus, etc.
    Type: Application
    Filed: December 29, 2014
    Publication date: September 28, 2017
    Inventors: Pil Ho KIM, Seung Shik SHIN, Kyuong Sik CHIN
  • Publication number: 20160297789
    Abstract: Disclosed are novel indanone derivatives, pharmaceutically acceptable salts thereof or enantiomers, a preparation method thereof, and a pharmaceutical composition for the prevention or treatment of viral diseases, comprising the same as an active ingredient. The indanone derivatives have excellent inhibitory activity against picornaviruses including coxsackie-, entero-, echo-, Polio-, and rhinoviruses, as well as exhibiting low cytotoxicity, so that they can be useful as an active ingredient of a pharmaceutical composition for the prevention or treatment of viral diseases including poliomyelitis, paralysis, acute hemorrhagic conjunctivitis, viral meningitis, hand-foot-and-mouth disease, vesicular disease, hepatitis A, myositis, myocarditis, pancreatitis, diabetes, epidemic myalgia, encephalitis, cold, herpangina, foot-and-mouth disease, asthma, chronic obstructive pulmonary disease, pneumonia, sinusitis or otitis media.
    Type: Application
    Filed: June 22, 2016
    Publication date: October 13, 2016
    Inventors: Young Sik JUNG, Chong Kgo LEE, Hae Soo KIM, Hee Chun JEONG, Pil Ho KIM, Soo Bong HAN, Jin Soo SHIN, Johan NEYTS, Hendrik Jan THIBAUT
  • Patent number: 9464067
    Abstract: Disclosed are indanone derivatives, pharmaceutically acceptable salts thereof or enantiomers, a preparation method thereof, and a pharmaceutical composition for the prevention or treatment of viral diseases, comprising the same as an active ingredient. The indanone derivatives have excellent inhibitory activity against picornaviruses including coxsackie-, entero-, echo-, Polio-, and rhinoviruses, as well as exhibiting low cytotoxicity, so that they can be useful as an active ingredient of a pharmaceutical composition for the prevention or treatment of viral diseases including poliomyelitis, paralysis, acute hemorrhagic conjunctivitis, viral meningitis, hand-foot-and-mouth disease, vesicular disease, hepatitis A, myositis, myocarditis, pancreatitis, diabetes, epidemic myalgia, encephalitis, cold, herpangina, foot-and-mouth disease, asthma, chronic obstructive pulmonary disease, pneumonia, sinusitis or otitis media.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: October 11, 2016
    Assignees: Katholieke Universiteit Leuven K.U. Leuven R & D, Korea Research Institute of Chemical Technology
    Inventors: Young Sik Jung, Chong Kgo Lee, Hae Soo Kim, Hee Chun Jeong, Pil Ho Kim, Soo Bong Han, Jin Soo Shin, Johan Neyts, Hendrik Jan Thibaut
  • Patent number: 9437790
    Abstract: The polyester resin composition of the present invention is characterized by comprising: (A) 100 parts by weight of a high heat resistant polyester resin having a main chain formed by a structure derived from aromatic dicarboxylic acid and alicyclic diol, wherein the melting point of the high heat resistant polyester resin is 200° C. or more; (B) 0.1 to 80 parts by weight of white pigment; and (C) 1 to 40 parts by weight of polyolefin copolymer. The resin composition of the present invention further comprises 1 to 40 parts by weight of a high stiffness polyester resin having a main chain comprising a structure derived from aromatic dicarboxylic acid and aliphathic diol. The molding foam, which is obtained from the polyester resin composition and the manufactured polyester resin composition, has good flexibility, heat resistance, and yellowing resistance and can be used for an LED reflecting plate due to having improved impact strength.
    Type: Grant
    Filed: December 26, 2012
    Date of Patent: September 6, 2016
    Assignee: Cheil Industries Inc.
    Inventors: Pil Ho Kim, In Sik Shim, Jong Cheol Lim, Sun Ho Song, Sang Hwa Lee